Steven Cohen’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.3M Buy
2,514,696
+509,117
+25% +$3.52M 0.02% 934
2026
Q2
$12.5M Sell
2,005,579
-1,199,917
-37% -$5.18M 0.01% 1145
2026
Q1
$9.07M Buy
3,205,496
+357,697
+13% +$1.21M 0.01% 1314
2025
Q4
$9.26M Buy
2,847,799
+2,815,057
+8,598% +$9.48M 0.01% 1405
2025
Q3
$94K Buy
+32,742
New +$83.6K ﹤0.01% 2211
2024
Q4
– Sell
-1,026,749
Closed -$8.53M – 2314
2024
Q3
$8.53M Sell
1,026,749
-2,492,812
-71% -$21.5M 0.02% 698
2024
Q2
$25.2M Buy
3,519,561
+2,109,199
+150% +$18.2M 0.07% 344
2024
Q1
$12.2M Buy
1,410,362
+459,162
+48% +$3.11M 0.03% 643
2023
Q4
$6.23M Buy
+951,200
New +$6.15M 0.02% 844
2023
Q3
– Sell
-460,111
Closed -$5.72M – 2731
2023
Q2
$5.72M Buy
+460,111
New +$6.21M 0.02% 769
2022
Q4
– Sell
-151,000
Closed -$3.86M – 1694
2022
Q3
$3.86M Buy
+151,000
New +$3.79M 0.02% 794
2022
Q1
– Sell
-390,900
Closed -$13.1M – 1307
2021
Q4
$16.4M Buy
390,900
+261,412
+202% +$10.6M 0.07% 379
2021
Q3
$6.36M Buy
+129,488
New +$6.32M 0.03% 608
2021
Q1
– Sell
-493,883
Closed -$13.9M – 1099
2020
Q4
$13.9M Buy
+493,883
New +$13.8M 0.07% 366

Other funds holding MRVI

Steven Cohen's MRVI Position: Q3 2026 in Review

Steven Cohen increased its Maravai LifeSciences (MRVI) stake by 25% in Q3 2026, buying an estimated $3.52M and bringing the position to 2,514,696 shares worth $19.3M. The position accounts for 0.02% of the portfolio, ranked #934.

Steven Cohen first reported a position in MRVI in Q4 2020 and has held it in 14 quarters since. The position peaked at $25.2M in Q2 2024. 200 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Steven Cohen held 2,514,696 shares of Maravai LifeSciences worth $19.3M as of Q3 2026.
  • Steven Cohen bought 509,117 Maravai LifeSciences shares in Q3 2026, an estimated $3.52M.
  • Maravai LifeSciences made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #934 holding.
  • Steven Cohen first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 14 quarters since.
  • Steven Cohen's Maravai LifeSciences position peaked at $25.2M in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.